scolopamine transdermal system

CHEBI:CHEBI_746945

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
226552
brand_name
Scopolamine Trandermal System
brand_name_base
Scopolamine Trandermal System
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
marketing_category
ANDA
active_ingredient_strength
1 mg/1
pharm_class_epc
Anticholinergic [EPC]
pharm_class
Cholinergic Antagonists [MoA]
pharm_class_moa
Cholinergic Antagonists [MoA]
labeler_name
Padagis Israel Pharmaceuticals Ltd
manufacturer_name
Padagis Israel Pharmaceuticals Ltd
package_marketing_start_date
20170613
dosage_form
PATCH, EXTENDED RELEASE
route
TRANSDERMAL
generic_name
scolopamine transdermal system
product_ndc
63629-8451
application_number
ANDA078830
marketing_start_date
20170613
spl_id
a54f6d59-ff74-4a21-9e4f-9242c049ce86
active_ingredient_name
SCOPOLAMINE
package_ndc
63629-8451-1
package_description
10 POUCH in 1 CARTON (63629-8451-1) / 1 PATCH, EXTENDED RELEASE in 1 POUCH (63629-8451-2)
unii
DL48G20X8X
spl_set_id
1099a330-fcb8-4acd-9ef8-525024c6b9d6
nui
N0000175370
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class